The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, placebo-controlled, crossover design trial will be used to test
the effect of exenatide on alcohol self-administration and craving following a priming dose
of alcohol. The specific objective of this research is to determine whether exenatide has
effects on alcohol consumption.
Phase:
Phase 1
Details
Lead Sponsor:
Boston Medical Center
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)